MARISA WESH: Open Payments
NPI 1174221832 · WHITING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 25 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lundbeck LLC | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Hologic Sales and Service, LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: Korlym, REXULTI, FARXIGA, CAPLYTA, XHANCE, VOQUEZNA, NOVASURE, GEMTESA.
Industry payments across NJ — which companies pay providers there.
